Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers Health (NYSE:HIMS) Announces Quarterly Earnings Results, Beats Expectations By $0.26 EPS

Hims & Hers Health (NYSE:HIMS - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.32…

Hims & Hers stock maintains buy rating with TD Cowen after solid 3Q24 By Investing.com

Hims & Hers stock maintains buy rating with TD Cowen after solid 3Q24…

Whats Going On With Hims & Hers Health Stock Tuesday? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Tuesday after the company reported strong third-quarter results and…

Hims & Hers Health: Another Blowout Quarter Ignored (NYSE:HIMS)

Hims & Hers Health exceeded revenue expectations, achieved substantial subscriber growth, and remains undervalued in the market. Learn more HIMS…

Hims & Hers will start selling a generic weight loss drug

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of…

Hims & Hers will start selling a generic weight loss drug

The telehealth company will start offering a generic version of liraglutide in 2025 as consumers continue to struggle to secure…

Hims & Hers Health (NYSE:HIMS) Shares Gap Up After Better-Than-Expected Earnings

Hims & Hers Health (NYSE:HIMS) Shares Gap Up on Strong Earnings…

Revenue Soars 77% for Hims & Hers Health, Inc. in Q3 2024

In the third quarter, the brands eclipsed two million subscribers on its platform, with more than 1 million utilizing a…

Hims & Hers Reports High Success Rate in GLP-1 Program

Hims & Hers has released a white paper showing that 87% of its GLP-1 weight loss program customers are close…

Hims & Hers Stock Soars: First Generic Weight Loss Drug to Shake Up Billion-Dollar Market

Shares jump over 5% as Hims & Hers unveils plans for the first generic GLP-1--targeting Novos weight-loss dominance…

HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin Contracts

Hims & Hers both revenue channels witness strong revenue growth on the back of solid product demand in the third…

Hims & Hers Soars Pre-Market After Analysts Boost Price Targets On Strong Q3 Performance

Hims & Hers Health raised its full-year sales guidance to $1.46 billion to $1.465 billion, up from a forecast in…

Hims & Hers price target raised to $32 from $28 at Seaport Research

Seaport Research raised the firm’s price target on Hims Hers to $32 from $28 and keeps a Buy rating…

Canaccord Genuity Group Increases Hims & Hers Health (NYSE:HIMS) Price Target to $28.00

Canaccord Genuity Group lifted their target price on Hims & Hers Health from $24.00 to $28.00 and gave the company…

Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator…

Stocks making the biggest moves premarket: Trump Media, Hims & Hers, Palantir and more

These are the stocks posting the largest moves in premarket trading.…

Hims & Hers boomt: Anhaltender GLP-1-Engpass und kostengünstige Alternativen treiben Nachfrage im Gewichtsmanagement

Hims & Hers Health, Inc. hat im 3. Quartal 2024 beeindruckende Ergebnisse erzielt und die Erwartungen der Analysten deutlich übertroffen.…

Hims & Hers price target raised to $21 from $18 at Piper Sandler

Piper Sandler analyst Korinne Wolfmeyer raised the firm’s price target on Hims Hers to $21 from $18 and keeps…

Hims & Hers to launch a generic for Novo’s older GLP-1

Hims & Hers Health (NYSE:HIMS) is gearing up to launch an off-patent version of Novo Nordisks (NVO) (OTCPK:NONOF) older GLP-1…

Hims & Hers to launch a generic GLP-1 (HIMS:NYSE)

Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version…

Hims & Hers price target raised to $28 from $24 at Canaccord

Canaccord raised the firm’s price target on Hims Hers to $28 from $24 and keeps a Buy rating on…

Hims and Hers stock gets boost from BofA as marketing spend fuels user growth By Investing.com

Hims and Hers stock gets boost from BofA as marketing spend fuels user growth…

Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion By Investing.com

Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion…

Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion By Investing.com

Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion…

Hims & Hers Health Inc (HIMS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion

With a 77% revenue increase and a growing subscriber base, Hims & Hers Health Inc (HIMS) continues to innovate in…

Vanguard Group Incs Strategic Acquisition in Hims & Hers Health Inc

Overview of the Recent Transaction On September 30, 2024, Vanguard Group Inc, a prominent investment firm, expanded its portfolio by…

Hims & Hers Health Inc (HIMS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

With a 77% revenue increase and a growing subscriber base, Hims & Hers Health Inc (HIMS) continues to innovate in…

Hims & Hers Health Reports Strong Q3 2024 Growth

Hims & Hers Health, Inc. ( ($HIMS) ) has released its Q3 earnings. Here is a breakdown of the information…

Hims & Hers: A Lot More Than Just GLP-1, And Its Proving Its Ability To Grow

…

Hims & Hers: A Lot More Than Just GLP-1, And Its Proving Its Ability To Grow (HIMS)

Hims & Hers strong Q3 results and revenue growth demonstrate its robust business. Click here to see why HIMS stock…

Hims & Hers Health, Inc. (HIMS) Q3 2024 Earnings Call Transcript

…

Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences.

Hims & Hers Health (HIMS) shares jumped in extended trading after the company reported better than expected third quarter revenue…

HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin Contracts

Hims & Hers both revenue channels witness strong revenue growth on the back of solid product demand in the third…

Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’

Shares of Hims & Hers Health Inc. rallied after hours on Monday after the wellness platform bumped its full-year sales…

Hims & Hers to stop reporting on orders, average order value after 2024

Says trajectory in 2024 “nothing short of phenomenal.” Says business trajectory setting “robust foundation” for 2025. Comments taken from Q3…

Hims & Hers Health, Inc. (HIMS) Q3 Earnings Match Estimates

Hims & Hers Health, Inc. (HIMS) came out with quarterly earnings of $0.06 per share, in line with the Zacks…

Hims & Hers Health, Inc. (HIMS) Q3 Earnings Match Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 0% and 4.52%, respectively, for the quarter ended September…

Hims & Hers up 7% on raised 2024 revenue guidance, Q3 beats

Hims & Hers Health stock jumps 7% in after-hours trading after raising 2024 revenue guidance and beating Q3 financial results.…

IBD 50s No. 2 Stock, Hims & Hers, Smashes Estimates On Robust Obesity Trajectory

Hims stock jumped late Monday after the online pharmacy beat expectations, helped by Hims & Hers weight-loss drug.…

Hims & Hers Health Reports Better-Than-Expected Q3 Results: Details - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health reported its third-quarter results after Mondays closing bell. Heres a look at the details from the…

Hims & Hers reports Q3 EPS 32c, consensus 4c

Reports Q3 revenue $401.6M, consensus $382.2M. “Improving momentum in both the Hims and Hers brands delivered another strong quarter of…

IBD 50s No. 2 Stock Crushes Views On Robust Obesity Path

Hims stock jumped late Monday after the online pharmacy beat expectations, helped by Hims & Hers weight-loss drug.…

Hims & Hers Health Q3 earnings beat estimates, raises guidance By Investing.com

Hims & Hers Health Q3 earnings beat estimates, raises guidance…

Hims & Hers Health Q3 earnings beat estimates, raises guidance By Investing.com

Hims & Hers Health Q3 earnings beat estimates, raises guidance…

Hims & Hers Health Q3 earnings beat estimates, raises guidance By Investing.com

Hims & Hers Health Q3 earnings beat estimates, raises guidance…

Hims Hers Health earnings beat by $0.22, revenue topped estimates By Investing.com

Hims Hers Health earnings beat by $0.22, revenue topped estimates…

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results

Hims & Hers Health reports stunning 77% revenue surge to $401.6M in Q3, achieving profitability with $75.6M net income. See…

Whats Going On With Hims & Hers Health Stock Monday? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health will report third-quarter financial results after the market close on Monday. Analysts expect the company to…

Hims & Hers Health Inc (HIMS) Shares Up 3.71% on Nov 4

Shares of Hims & Hers Health Inc (HIMS) surged 3.71% in mid-day trading on Nov 4. The stock reached an…

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today…